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Aims To evaluate the feasibility of papillary muscle shortening in a specific group of high risk patients with ischaemic mitral regurgitation undergoing mitral valve reconstruction.
Background From January 1996 to December 1997, 712 (10·1%) out of a total of 7042 open heart patients underwent mitral valve surgery in our hospital. Mitral valve reconstruction was performed in 408 of these patients (57·3%) and valve replacement had to be performed in 304 patients (42·7%).
Methods A specific technique of papillary muscle reconstruction was performed in 32 patients undergoing valve reconstruction (7·8%). These cases had degenerated and had developed fibrotic elongated papillary muscles, which resulted in prolapses of one or more parts of the mitral valve leaflets. The aetiology in this group of patients was ischaemic, requiring concomitant myocardial revascularization in 28 patients (87·5%) with a mean of 2·7 grafts/patient. All patients underwent papillary muscle shortening using a pericardium pledget-reinforced Polytetrafluoroethylene suture and annuloplasty with a Carpentier-Edwards Physio Annuloplasty Ring. Of these 32 patients, 17 (53·1%) were male, the mean age was 67·1 9·7 years (range 41 to 81 years) and all but one were in pre-operative NYHA class III or IV.
Introduction
In 1956 the first mitral annuloplasty was performed by Lillehei et al. [1] ; this was followed in 1968 by the first mitral valve reconstruction using a prosthetic ring performed by Carpentier [2] . Since then mitral valve surgery has evolved following the introduction of the 'functional approach' to valve reconstruction [3] . Some authors have found mitral valve reconstruction to be strikingly superior to valve replacement [4] [5] [6] , whereas others have noted little difference [7] [8] [9] . This diversity of opinion reflects the variety of techniques used, and the heterogenous nature and small numbers of the patient populations studied.
Patients with ischaemic mitral regurgitation are a surgical challenge. Mitral valve replacement combined with coronary artery bypass surgery is reported to have a peri-operative mortality of 19-53% [10] [11] [12] and some authors suggest, 'replace the valve without delay' [13] rather than achieve valve repair. Nevertheless, reparative procedures of the mitral valve, in comparison with valve replacement, have been shown to be associated with enhanced survival and lower rates of complications in patients with mitral regurgitation secondary to coronary artery disease [14, 15] . Revision submitted 9 June 1998, and accepted 10 June 1998. In this study, the clinical results and post-repair function of a specific papillary muscle shortening technique in patients with valve repair due to ischaemic mitral insufficiency are evaluated.
Methods
From 1 January 1996 to 31 December 1997, 7042 patients underwent open heart surgery in our hospital. The study population is a consecutive series of 712 patients who had mitral valve surgery during this period. Mitral valve reconstruction was performed in 408 patients (57·3%) and valve replacement had to be performed in 304 (42·7%).
A specific papillary muscle shortening technique was performed in 32 patients undergoing valve reconstruction (7·8%), 17 of whom were male (53·1%). The mean age was 67·1 9·7 years (range 41-81years); all but one patient were in NYHA class III or IV and had 3+ to 4+ mitral regurgitation. Pre-operative patient characteristics are listed in Table 1 and pre-operative echocardiographic parameters in Table 2 .
The operation was performed in ischaemic cardiac arrest under cardiopulmonary bypass with moderate systemic hypothermia and topical cooling, without cardioplegia. Twenty-eight patients required concomitant myocardial revascularization. The distal anastomoses were performed prior to mitral valve repair, with a mean of 2·7 grafts/patient; the proximal anastomoses were completed during the rewarming period. The coronary artery disease in the remaining four patients was of the peripheral type, involving smaller coronary arteries unsuitable for coronary artery bypass grafting.
To repair the mitral valve the inter-atrial groove was incised and the right atrium dissected. With the left atrial roof exposed, a left atrial incision was carried out close to the mitral valve. A self-retaining retractor was used to expose the mitral valve. All patients underwent papillary muscle shortening using a pericardium pledgetreinforced polytetrafluoroethylene (PTFE) suture (Gore-Tex Sutures, W.L. Gore & Associates, Flagstaff, Arizona, U.S.A.). (Fig. 1 shows the details of the surgical technique) and annuloplasty with a CarpentierEdwards Physio Annuloplasty Ring (Baxter Healthcare Corporation, Santa Ana, California, U.S.A.). Anatomical lesions are listed in Table 3 and associated procedures, as well as mitral valve repair details, are given in Table 4 . The mean aortic cross-clamp time was 47 7 min. Intra-operative Doppler echocardiography was routinely used, and all patients were studied before discharge from hospital.
Follow-up data collected in February 1998 were 100% complete. Postoperative events were categorized using the guidelines for reporting morbidity and mortality after cardiac valve operations [16] . All patients received oral anticoagulation from the third postoperative day (Phenprocoumon) its efficacy was assessed by the interantional normalized ratio. Providing the patient was in sinus rhythm, anticoagulation was discontinued after 3 months and replaced by antiplatelet therapy.
Results
Two patients died in hospital resulting in an operative mortality of 6·2%. The causes of these early deaths were secondary bleeding complications with tamponade, and low cardiac output following myocardial infarction. Peri-or postoperative complications are listed in Table  5 . There was one non-cardiac-related late death (3·1%). This patient died 3 months after surgery due to complications of a hepatic carcinoma.
Postoperative Doppler echocardiography showed satisfactory mitral valve function in all patients. Postoperative echocardiographic parameters listed in Table 6 show a slight reduction of left ventricular systolic and end-diastolic diameters as well as shortening fraction. While there was mild regurgitation in three patients and moderate valve regurgitation in two patients, there was no residual mitral valve regurgitation in 25 of all surviving patients (83·3%). Follow-up data collected in 02·98 were 100% complete. All patients were in NYHA functional class I or II at the time of this 
Discussion
This study, although small in numbers and short in follow-up, demonstrates the feasibility of a mitral valve reconstruction technique for a specific group of patients.
These 32 patients represent only 4·5% of the 712 patients undergoing mitral valve surgery in this period of time. Nevertheless, we were intrigued to study the feasibility and outcome of simple papillary muscle shortening in this group of high-risk patients with mitral regurgitation secondary to coronary artery disease.
Patients with ischaemic mitral regurgitation are a surgical challenge. The results after combined valve replacement and revascularization have been poor, with a reported peri-operative mortality of 19-53% [10] [11] [12] , and the optimal method of repair is still under discussion [10] . Papillary muscle dysfunction resulting in severe mitral regurgitation has been reported to occur with episodic, reversible ischaemia without infarction [17] , and reduction or elimination of mitral regurgitation may be expected if the ischaemia is relieved by revascularization. Nevertheless, improvement in ischaemic mitral regurgitation by revascularization alone is unusual [10] , and in patients who undergo coronary revascularization alone, uncorrected mitral regurgitation nearly doubles the risk of late death [18] . The results of mitral valvuloplasty for ischaemic disease are still very variable and depend not only on the experience of the surgeon but also on their aggressiveness with regard to the indications for surgery [6] . Controversial data are often reported, mainly due to the fact that studies that attribute mitral regurgitation to ischaemic causes, just because of associated coronary artery disease, may inappropriately assess the origin of the regurgitation as ischaemic [19] . It seems, however, that specifically in patients with ischaemic disease, the preservation and reconstruction of the papillary muscles and chordae during mitral valve reconstruction, as well as the lack of an artificial valve prosthesis, contribute to the enhanced systolic function with improved late survival and lower complication rates following mitral repair, as compared with replacement.
The hospital mortality of 6·2% for our group of patients compares favourably with the results of others, who reported a hospital mortality for this group of ischaemic patients between 13·6% and 26% for repair and 16·7% for replacement [14, 19] . Thus, our data, seem to support attempts to reconstruct the mitral valve if *Because multiple lesions were present in some patients, the total number of lesions is higher than the number of patients. CE=Carpentier-Edwards; PTFE=polytetrafluoroethylene; †Toronto SPV (stentless porcine valve). *Because multiple lesions were present in some patients, multiple procedures have been necessary, making the total number of procedures higher than the number of patients. 
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possible. We also do not share the opinion that patients with severe ischaemic mitral valve regurgitation in association with profoundly depressed left ventricular function should undergo mitral valve replacement instead of repair [13] , since 37·5% of our patients had a left ventricular ejection fraction of less than 0·4 and 6·3% of less than 0·2. Furthermore, one frequent argument in favour of a straightforward mitral valve replacement is the assumed prolonged time of ischaemic arrest required for a repair procedure compared to a replacement [13] . Our mean aortic cross-clamp time for performing these combined procedures, mitral reconstruction and coronary bypass surgery, was 47 7 min (range: 39 to 63 min). This is shorter than mean cross-clamp times of 52 to 61 min, described for isolated mitral valve procedures in the literature [19, 20] . There was no moderate or severe recurrent mitral regurgitation, no cardiac-related late death, no reoperations, or thromboembolic and bleeding complications during this short-term follow-up. While longerterm follow-up is mandatory, it has been shown that mitral valve reconstruction using a papillary muscle shortening technique, combined with coronary artery bypass grafting, can be accomplished with acceptable results, yielding reliable improvements, in symptoms and quality of life. We conclude that our described technique of papillary muscle shortening is a valuable tool in these high risk patients with ischaemic mitral regurgitation undergoing surgery, and that it is safe to achieve a repair procedure rather than just replace the valve.
